Atea Pharmaceuticals, Inc. 8-K

What Happened
Atea Pharmaceuticals, Inc. announced its financial results for the three months ended March 31, 2026 via a press release dated May 12, 2026. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8-K filed May 12, 2026 under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Press release announcing quarterly results dated May 12, 2026 and furnished as Exhibit 99.1 to the Form 8-K.
• Reporting period: three months ended March 31, 2026.
• Form 8-K filed under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (exhibits), with the Inline XBRL cover page file included.

Why It Matters
This filing signals Atea’s latest quarterly earnings and operational update; investors should review the Exhibit 99.1 press release for specifics on revenue, net income/loss, cash position, and any business updates or guidance that could affect the stock. Because the detailed figures are in the furnished press release (and later periodic filings), retail investors should read the press release and the company’s subsequent 10-Q for complete, audited financials and context.